Ayala Pharmaceuticals, Inc. (AYLA)

NASDAQ: AYLA · IEX Real-Time Price · USD
1.59
-0.02 (-1.24%)
At close: Aug 8, 2022 3:59 PM
1.58
-0.01 (-0.63%)
After-hours: Aug 8, 2022 7:30 PM EDT

Income Statement (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Revenue
0.461.150.630.760.9710.661.0510.370.850.850.27
Revenue Growth (YoY)
-52.98%14.14%-5.01%-27.18%-2.70%169.89%-22.13%22.65%277.74%----
Cost of Revenue
0.37-5.870.630.760.97-6.410.661.0510.380.490.160.27
Gross Profit
0.097.010007.42000-00.360.690
Selling, General & Admin
2.442.242.22.542.32.651.861.551.311.520.951.020.85
Research & Development
7.57.537.378.126.936.795.425.075.133.864.373.442.75
Operating Expenses
9.949.779.5710.669.239.447.286.616.445.385.324.463.6
Operating Income
-9.85-2.76-9.57-10.66-9.23-2.03-7.28-6.61-6.44-5.39-4.96-3.77-3.6
Interest Expense / Income
00.26000-0.060000000
Other Expense / Income
-0.026.840.060.020.097.380.04-0.040.04-0.040.05-0.1-0.14
Pretax Income
-9.84-9.85-9.63-10.68-9.32-9.35-7.32-6.57-6.48-5.34-5.01-3.67-3.46
Income Tax
0.190.20.170.160.250.050.120.140.120.080.040.110.08
Net Income
-10.03-10.05-9.8-10.84-9.57-9.4-7.44-6.71-6.6-5.42-5.05-3.78-3.54
Net Income Common
-10.03-10.05-9.8-10.84-9.57-9.4-7.44-6.71-6.6-5.42-5.05-3.78-3.54
Shares Outstanding (Basic)
15151414131013955555
Shares Outstanding (Diluted)
15151414131013955555
Shares Change
18.72%54.17%14.36%59.86%157.79%97.43%154.57%81.28%0.78%----
EPS (Basic)
-0.66-0.66-0.68-0.75-0.74-0.73-0.59-0.74-1.32-1.08-1.01-0.76-0.71
EPS (Diluted)
-0.66-0.66-0.68-0.75-0.74-0.73-0.59-0.74-1.32-1.08-1.01-0.76-0.71
Free Cash Flow Per Share
-0.65-0.51-0.65-0.80-0.75-0.70-0.70-0.59-1.28-0.85-1.04-0.63-0.76
Gross Margin
19.65%611.87%---738.64%----0.81%42.60%81.22%-
Operating Margin
-2151.53%-240.40%-1530.56%-1400.39%-947.43%-201.79%-1106.84%-632.82%-643.26%-1447.85%-586.63%-442.25%-1358.49%
Profit Margin
-2189.30%-876.88%-1567.36%-1424.57%-982.34%-936.06%-1130.39%-642.30%-659.14%-1457.80%-597.28%-444.01%-1335.47%
Free Cash Flow Margin
-2179.91%-679.93%-1499.04%-1517.87%-990.66%-691.63%-1353.04%-509.86%-640.46%-1135.75%-609.70%-367.96%-1421.89%
Effective Tax Rate
-1.92%-2.02%-1.73%-1.52%-2.66%-0.53%-1.57%-2.11%-1.87%-1.48%-0.78%-3.08%-2.17%
EBITDA
-9.81-9.56-9.58-10.75-9.16-9.36-7.27-6.54-6.42-5.24-4.99-3.66-3.44
EBITDA Margin
-2141.49%-834.38%-1533.28%-1412.48%-940.04%-932.27%-1105.47%-625.55%-641.76%-1408.87%-590.41%-429.81%-1299.62%
Depreciation & Amortization
0.030.030.05-0.070.160.040.050.040.050.10.020.010.02
EBIT
-9.84-9.59-9.63-10.68-9.32-9.4-7.32-6.57-6.48-5.34-5.01-3.67-3.46
EBIT Margin
-2148.04%-836.82%-1540.64%-1403.29%-956.88%-936.65%-1112.92%-629.00%-647.05%-1436.56%-592.66%-430.75%-1307.17%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).